Holen Sie sich die Stockscreener-App
1.06
1.92%
0.02
Handel nachbörslich:
1.02
-0.04
-3.77%
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.174 | 0.174 | 0.174 | 0.1839 |
| Cost Of Revenue |
-
|
- | - | - | 0.00272 |
| Gross Profit |
100.00%
-
|
0.174 | 0.174 | 0.174 | 0.1812 |
Operating Expenses
|
45.03%
1.5736
|
2.8626 | 3.9244 | 2.925 | 2.8719 |
| Depreciation and Amortization |
21.18%
0.0169
|
0.0214 | 0.031 | 0.00228 | 0.0332 |
| Operating Income/Loss |
41.47%
-1.5736
|
-2.6886 | -3.7504 | -2.751 | -2.6907 |
| Nonoperating Income/Loss |
155.83%
-0.0221
|
-0.00863 | -0.0402 | 0.034 | -0.0159 |
| Income/Loss From Continuing Operations Before Tax |
40.84%
-1.5957
|
-2.6972 | -3.7906 | -2.717 | -2.7066 |
| Income Tax Expense/Benefit |
0.00179
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
40.77%
-1.5975
|
-2.6972 | -3.7906 | -2.717 | -2.7066 |
|
Net Income/Loss
|
40.77%
-1.5975
|
-2.6972 | -3.7906 | -2.717 | -2.7066 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
79.57%
-0.0025
|
-0.00139 | -0.00151 | -0.00376 | -0.00293 |
| Diluted Average Shares |
3,965%
21.38
|
0.5259 | 18.30 | 17.51 | 16.67 |
| Diluted Earnings Per Share |
46.15%
-0.07
|
-0.13 | -0.21 | -0.15 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):